Valeant Pharmaceuticals International Inc (NYSE:VRX)

237.53
Delayed Data
As of May 22
 +4.26 / +1.83%
Today’s Change
106.00
Today|||52-Week Range
238.49
+65.98%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 249.50, with a high estimate of 275.00 and a low estimate of 170.00. The median estimate represents a +5.04% increase from the last price of 237.53.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.44
Sales
$2.5B
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.20%
 
 
 
 
 
 
Growthannually 32.91%
 
 
 
 
 
 

Sales

Growthquarterly 14.40%
 
 
 
 
 
 
Growthannually 26.20%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account